OTX-CSI

Ocular Therapeutix announces first patient dosed in phase 1 clinical trial of OTX-CSI to treat dry eye disease
Pharmaceutical Business Review
Wed, 05/13/20 - 10:50 am
Ocular Therapeutix
dry eye disease
clinical trials
OTX-CSI